Analysing the protection from respiratory tract infections and allergic diseases early in life by human milk components: the PRIMA birth cohort.

Saved in:
Bibliographic Details
Title: Analysing the protection from respiratory tract infections and allergic diseases early in life by human milk components: the PRIMA birth cohort.
Authors: van Stigt AH; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Oude Rengerink K; Department of Biostatistics and Research Support, Clinical Trial Methodology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Bloemenkamp KWM; Department of Gynaecology and Obstetrics, University Medical Center Utrecht, Utrecht, The Netherlands., de Waal W; Department of Pediatrics, Diakonessenhuis, Utrecht, The Netherlands., Prevaes SMPJ; Department of Pediatric Pulmonology and Allergology, Wilhelmina Children's Hospital/University Medical Center, Utrecht University, Utrecht, The Netherlands., Le TM; Department of Dermatology/Allergology, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands., van Wijk F; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Nederend M; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Hellinga AH; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Lammers CS; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., den Hartog G; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., van Herwijnen MJC; Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands., Garssen J; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Danone Nutricia Research, Utrecht, The Netherlands., Knippels LMJ; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Danone Nutricia Research, Utrecht, The Netherlands., Verhagen LM; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands., de Theije CGM; Department of Neonatology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands., Lopez-Rincon A; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Leusen JHW; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Van't Land B; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.; Danone Nutricia Research, Utrecht, The Netherlands., Bont L; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands. L.Bont@umcutrecht.nl.; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands. L.Bont@umcutrecht.nl.; ReSViNET Foundation, Zeist, The Netherlands. L.Bont@umcutrecht.nl.
Corporate Authors: PRIMA Initiative Group
Source: BMC infectious diseases [BMC Infect Dis] 2022 Feb 14; Vol. 22 (1), pp. 152. Date of Electronic Publication: 2022 Feb 14.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1471-2334
DOI:10.1186/s12879-022-07107-w